High Energy Physics - Lattice
[Submitted on 24 Sep 2010]
Title:Chiral transition and deconfinement transition in QCD with the highly improved staggered quark (HISQ) action
View PDFAbstract:We report preliminary results on the chiral and deconfinement aspects of the QCD transition at finite temperature using the Highly Improved Staggered Quark (HISQ) action on lattices with temporal extent of N_{\tau}=6 and 8. The chiral aspects of the transition are studied in terms of quark condensates and the disconnected chiral susceptibility. We study the deconfinement transition in terms of the strange quark number susceptibility and the renormalized Polyakov loop. We made continuum estimates for some quantities and find reasonably good agreement between our results and the recent continuum extrapolated results obtained with the stout staggered quark action.
Current browse context:
hep-lat
References & Citations
Bibliographic and Citation Tools
Bibliographic Explorer (What is the Explorer?)
Connected Papers (What is Connected Papers?)
Litmaps (What is Litmaps?)
scite Smart Citations (What are Smart Citations?)
Code, Data and Media Associated with this Article
alphaXiv (What is alphaXiv?)
CatalyzeX Code Finder for Papers (What is CatalyzeX?)
DagsHub (What is DagsHub?)
Gotit.pub (What is GotitPub?)
Hugging Face (What is Huggingface?)
Papers with Code (What is Papers with Code?)
ScienceCast (What is ScienceCast?)
Demos
Recommenders and Search Tools
Influence Flower (What are Influence Flowers?)
CORE Recommender (What is CORE?)
arXivLabs: experimental projects with community collaborators
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.